Cannabis firm Organigram rises on Q2 profit, revenue jump
** U.S.-listed shares of pot firm Organigram OGI.TO, OGI.N rise 10.2% to $1.3 premarket ** Company posts Q2 profit and a jump in revenue on higher international sales and contributions from its Motif acquisition ** Company posts Q2 net income of $42.5 million compared with a loss of $27.1 million a year ago ** Q2 gross revenue rises to $102.8 million, up 79% from a year ago ** As of last close, shares are down 28.7% YTD (Reporting by Katha Kalia in Bengaluru) ((Katha.Kalia@thomsonreuters.com))
Recent news on Organigram Global
See all newsBrief: Organigram Global Expects Annualized Run-Rate Cost Savings Of $8 Million-$10 Million In Fiscal 2027
Canada's Organigram Q3 revenue beats on Sanity acquisition; CFO to exit
Brief: Organigram Q3 Revenue CAD 105.782 Million Vs. IBES Estimate CAD 98.8 Million
Brief: Organigram Provides Business Update Highlighting Initial Sanity Performance And Canadian Market Share
Canada cannabis producer Organigram's Q2 net revenue falls more than expected